Others stimulate the body's own growth hormone production
Preclinical and clinical safety data includes [5] : No evidence of mutagenic activity, chromosomal aberrations, or micronucleus formation in genotoxicity studies 6-month chronic oral administration studies in rats showed no toxicological concerns 9-month studies in cynomolgus monkeys revealed general safety Six human clinical trials spanning 0.25 mg to 30 mg doses for up to 6 months No serious adverse events or withdrawals related to AOD9604 intake No anti-AOD9604 antibodies detected, indicating low immunogenic potential No changes in vital signs, physical examinations, electrocardiograms, or safety-related laboratory parameters Research Applications A Quick Review AOD9604 is a peptide compound that has shown potential in research related to lipid metabolism, energy balance, and tissue regeneration
Neurotransmitter Balance: Imbalances in neurotransmitters, such as serotonin and dopamine, can contribute to mood disorders and behavioral abnormalities
Supplementary Tables: Table S1
Research demonstrates that individuals with recurrent aphthous stomatitis frequently present with lower B12 levels, and correcting this deficiency can reduce ulcer frequency and severity